Your browser doesn't support javascript.
loading
Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients.
Shimoda, Yukiko; Shibaki, Ryota; Yoshida, Tatsuya; Murakami, Shuji; Shirasawa, Masayuki; Torasawa, Masahiro; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Yamamoto, Noboru; Ohe, Yuichiro; Motoi, Noriko.
Afiliación
  • Shimoda Y; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan; Cancer Medicine, Cooperative Graduate School, The Jikei University Graduate School of Medicine, Tokyo, Minato-ku, Tokyo, Japan.
  • Shibaki R; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan; Department of Experimental Therapeutics, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan. Electronic address: tatyoshi@ncc.go.jp.
  • Murakami S; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa Japan.
  • Shirasawa M; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Torasawa M; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Matsumoto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Masuda K; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Shinno Y; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Okuma Y; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Horinouchi H; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Yamamoto N; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan; Department of Experimental Therapeutics, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan; Cancer Medicine, Cooperative Graduate School, The Jikei University Graduate School of Medicine, Tokyo, Minato-ku, Tokyo, Japan.
  • Motoi N; Department of Diagnostic Pathology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Clin Lung Cancer ; 23(6): 477-486, 2022 09.
Article en En | MEDLINE | ID: mdl-35644780
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Japón